Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2006 1
2009 1
2010 1
2012 2
2016 1
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Apelin/APJ system and cancer.
Yang Y, Lv SY, Ye W, Zhang L. Yang Y, et al. Clin Chim Acta. 2016 Jun 1;457:112-6. doi: 10.1016/j.cca.2016.04.001. Epub 2016 Apr 13. Clin Chim Acta. 2016. PMID: 27083318 Review.
Apelin/APJ system has a wide tissue distribution in the brain as well as in peripheral organs including heart, lung, vessels, and adipose tissue. ...In this article, we summarize the role of apelin/APJ system on lung cancer, gastroesophageal and colonic cance …
Apelin/APJ system has a wide tissue distribution in the brain as well as in peripheral organs including heart, lung, vessels, …
Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions.
Poto R, Loffredo S, Palestra F, Marone G, Patella V, Varricchi G. Poto R, et al. Cells. 2022 May 23;11(10):1720. doi: 10.3390/cells11101720. Cells. 2022. PMID: 35626756 Free PMC article. Review.
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation, predominantly affecting the lung parenchyma and peripheral airways, that results in progressive and irreversible airflow obstruction. ...There is compelling evidence that effector …
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation, predominantly affecting the lung parenchyma an …
Von Willebrand factor and angiogenesis: basic and applied issues.
Randi AM, Laffan MA. Randi AM, et al. J Thromb Haemost. 2017 Jan;15(1):13-20. doi: 10.1111/jth.13551. J Thromb Haemost. 2017. PMID: 27778439 Free article. Review.
Investigation of these pathways has been greatly facilitated by the ability to isolate EC from progenitors circulating in the peripheral blood of normal controls and patients with VWD. In the next few years, these will yield further evidence on the molecular pathways contr …
Investigation of these pathways has been greatly facilitated by the ability to isolate EC from progenitors circulating in the peripheral …
Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function.
Ushio-Fukai M, Urao N. Ushio-Fukai M, et al. Antioxid Redox Signal. 2009 Oct;11(10):2517-33. doi: 10.1089/ars.2009.2582. Antioxid Redox Signal. 2009. PMID: 19309262 Free PMC article. Review.
Neovascularization is involved in normal development and wound repair as well as ischemic heart disease and peripheral artery disease. ...Stem/progenitor cells have been used for cell-based therapy to promote revascularization after peripheral or myocardial i …
Neovascularization is involved in normal development and wound repair as well as ischemic heart disease and peripheral artery …
Genetic modification of ex-vivo expanded stem cells for clinical application.
Aggarwal R, Pompili VJ, Das H. Aggarwal R, et al. Front Biosci (Landmark Ed). 2010 Jun 1;15(3):854-71. doi: 10.2741/3650. Front Biosci (Landmark Ed). 2010. PMID: 20515730 Free PMC article. Review.
However, the number of HSCs obtained from sources like bone marrow, peripheral or umbilical cord blood is not sufficient for routine clinical application. ...
However, the number of HSCs obtained from sources like bone marrow, peripheral or umbilical cord blood is not sufficient for routine …
Endothelial progenitor cells: current issues on characterization and challenging clinical applications.
Resch T, Pircher A, Kähler CM, Pratschke J, Hilbe W. Resch T, et al. Stem Cell Rev Rep. 2012 Sep;8(3):926-39. doi: 10.1007/s12015-011-9332-9. Stem Cell Rev Rep. 2012. PMID: 22095429 Review.
Recent research is focused on three major questions: The fact that the number of EPC in peripheral blood is exceedingly low has consistently raised suspicion whether these cells can plausibly have an impact on physiological or pathophysiological processes. ...
Recent research is focused on three major questions: The fact that the number of EPC in peripheral blood is exceedingly low has consi …
Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma.
Kleinerman ES, Maeda M, Jaffe N. Kleinerman ES, et al. Cancer Treat Res. 1993;62:101-7. doi: 10.1007/978-1-4615-3518-8_14. Cancer Treat Res. 1993. PMID: 8096724 Review.
We have further demonstrated in phase I and phase II trials that liposomal MTP-PE can be given safely i.v. to both adults and children with minimal side effects. The findings of peripheral fibrosis with neovascularization and infiltration of the tumor with chronic i …
We have further demonstrated in phase I and phase II trials that liposomal MTP-PE can be given safely i.v. to both adults and children with …
[PEDF: an endogenous factor displaying potent neuroprotective, neurotrophic, and antiangiogenic activity].
Marciniak K, Butwicka A, Nowak JZ. Marciniak K, et al. Postepy Hig Med Dosw (Online). 2006;60:387-96. Postepy Hig Med Dosw (Online). 2006. PMID: 16885909 Review. Polish.
The presence of PEDF was confirmed in several structures of the eye and other organs (i.e. liver, lung, kidney) in both prenatal and postnatal life, and in almost all parts of the central nervous system. ...PEDF is capable of regulating many physiological processes; for ex …
The presence of PEDF was confirmed in several structures of the eye and other organs (i.e. liver, lung, kidney) in both prenatal and …
Fibroblast growth factor-mediated angiogenesis for the treatment of ischemia. Lessons learned from experimental models and early human experience.
Gonçalves LM. Gonçalves LM. Rev Port Cardiol. 1998 Oct;17 Suppl 2:II11-20. Rev Port Cardiol. 1998. PMID: 9835778 Review.
The experimental evidence for the potential for FGFs as therapeutic agents for the treatment of progressive myocardial ischemia, acute myocardial ischemia, and peripheral limb ischemia is also analyzed. It is not known to what extent the results of animal studies can be ex …
The experimental evidence for the potential for FGFs as therapeutic agents for the treatment of progressive myocardial ischemia, acute myoca …